Central Asset Investments & Management Holdings’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Central Asset Investments & Management Holdings’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-68,815	Closed	-$2.97M	–	65
2015 Q3	$2.97M	Buy	+68,815	New	+$2.9M	3.26%	12

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Central Asset Investments & Management Holdings's WX Position: Q4 2015 in Review

Central Asset Investments & Management Holdings sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 68,815 shares — an estimated $2.97M sold.

Central Asset Investments & Management Holdings first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $2.97M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Central Asset Investments & Management Holdings reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Central Asset Investments & Management Holdings sold 68,815 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.97M.
Central Asset Investments & Management Holdings first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
Central Asset Investments & Management Holdings's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.97M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Central Asset Investments & Management Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.